Xiangdong Cheng, Zhengbo Song, Ning Li, Liang Han, Yongchang Zhang, Tongsen Zheng, Aili Suo, Zhe Zhang, Hongli Li, Xiaobo Du, Jian Zhang, Shuang Zhang, Liu Hong, Li Xiang, Qing Peng, Xunqiang Wang, Ding Yu, Wenwen Hu, Huan Wang. "First in human phase I study of TQB2103, a Claudin18.2 (CLDN18.2) targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3026